Linked Data API

Show Search Form

Search Results

173519
registered interest false more like this
date remove filter
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Pregnancy: Sodium Valproate more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government, following the findings of the European Medicines Agency review of Valproate in pregnancy, and the past issue of the availability of information to patients, why the new instructions from the European Medicines Agency have not become mandatory. more like this
tabling member printed
Baroness Masham of Ilton more like this
uin HL4101 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-26more like thismore than 2015-01-26
answer text <p>Sodium valproate has been authorised since the early 1970’s for the treatment of epilepsy. It was known at the time of licensing that valproate was associated with an increased risk of birth defects and it was authorised for the treatment of women of childbearing potential only where other treatments were ineffective. The authorised product information (Summary of Product Characteristics or SPC and Patient Information Leaflet or PIL) contain warnings about the risks associated with use in pregnancy.</p><p> </p><p> </p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) initiated a Europe-wide review of the risk of developmental disorders in October 2013 following publication of studies which provided further information on the magnitude and nature of the risk of developmental disorders in children born to mothers who took valproate in pregnancy. The Europe-wide review, led by the United Kingdom and the Netherlands, was completed in November 2014 and MHRA is working to fully implement the conclusions of that review which are binding in all Member States. There will be a mandatory requirement for all manufacturers to update the valproate SPC and PIL with strengthened warnings and in addition new educational materials will be provided to healthcare professionals and patients.</p><p> </p>
answering member printed Earl Howe remove filter
grouped question UIN HL4102 more like this
question first answered
less than 2015-01-26T12:28:03.583Zmore like thismore than 2015-01-26T12:28:03.583Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
1850
label Biography information for Baroness Masham of Ilton more like this
173520
registered interest false more like this
date remove filter
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Pregnancy: Sodium Valproate more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government whether they intend to issue an apology for the failure to inform female patients of the dangers of Valproate in pregnancy and the harm caused to children as a result. more like this
tabling member printed
Baroness Masham of Ilton more like this
uin HL4102 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-26more like thismore than 2015-01-26
answer text <p>Sodium valproate has been authorised since the early 1970’s for the treatment of epilepsy. It was known at the time of licensing that valproate was associated with an increased risk of birth defects and it was authorised for the treatment of women of childbearing potential only where other treatments were ineffective. The authorised product information (Summary of Product Characteristics or SPC and Patient Information Leaflet or PIL) contain warnings about the risks associated with use in pregnancy.</p><p> </p><p> </p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) initiated a Europe-wide review of the risk of developmental disorders in October 2013 following publication of studies which provided further information on the magnitude and nature of the risk of developmental disorders in children born to mothers who took valproate in pregnancy. The Europe-wide review, led by the United Kingdom and the Netherlands, was completed in November 2014 and MHRA is working to fully implement the conclusions of that review which are binding in all Member States. There will be a mandatory requirement for all manufacturers to update the valproate SPC and PIL with strengthened warnings and in addition new educational materials will be provided to healthcare professionals and patients.</p><p> </p>
answering member printed Earl Howe remove filter
grouped question UIN HL4101 more like this
question first answered
less than 2015-01-26T12:28:03.67Zmore like thismore than 2015-01-26T12:28:03.67Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
1850
label Biography information for Baroness Masham of Ilton more like this
173537
registered interest false more like this
date remove filter
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Medicine: Education more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 24 October 2014 (HL2125 and HL2126) and 1 July 2013 (WA 191–2), why the review of medical and dental student intakes recommended by the Health and Education National Strategic Exchange for 2014, which was to be led by Health Education England, did not take place; and why, in its absence, they reconsidered the policy of reducing student intake. more like this
tabling member printed
Lord Laird more like this
uin HL4119 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-26more like thismore than 2015-01-26
answer text <p>Health Education England (HEE) plans to undertake a review of the medical student intake in 2015 in the context of the HEE Strategic Framework 15, the HEE Workforce Plan for England 2015-16, and the recently published NHS England Five Year Forward View.</p><p> </p><p> </p><p> </p><p>Working with the Chief Dental Officer for England, HEE took the decision to recommend a reduction in the 2014 student dental intake by 10%. This was in response to a number of issues including detailed analysis supplied by the Centre for Workforce Intelligence that highlighted key changes in the improvement in dental health within England and the need for NHS England to ensure it had available the appropriate workforce to meet the needs of the service going forward.</p><p> </p> more like this
answering member printed Earl Howe remove filter
question first answered
less than 2015-01-26T12:46:52.017Zmore like thismore than 2015-01-26T12:46:52.017Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
2479
label Biography information for Lord Laird more like this
173538
registered interest false more like this
date remove filter
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading General Practitioners more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 24 October 2014 (HL2125 and HL2126), what plans they have to address the current shortage of general practitioners; whether they will review their decision to reduce the number of students entering medical school this year; and whether they intend to rely on foreign medical graduates coming to this country to fill vacancies for the foreseeable future. more like this
tabling member printed
Lord Laird more like this
uin HL4120 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-26more like thismore than 2015-01-26
answer text <p><em>There are more than 1,000 more general practitioners (GPs) now working and training in the National Health Service than from the position in September 2010, the most recent figures after the General Election – these data are published once a year in September. The next census as at 30 September 2014 will be published in March 2015.</em></p><p> </p><p><em> </em></p><p> </p><p><em>Transforming Primary Care </em>set out the intention to make available around 10,000 primary and community health and care professionals by 2020, in support of the shift in how care will be provided. Bringing forward substantial numbers of new GPs through training is a key part of this, and Health Education England’s (HEE) mandate commitment will increase the total number of GPs available by 5,000.</p><p> </p><p><em> </em></p><p> </p><p><em>In order to understand the needs of the primary care workforce of the future, HEE has commissioned an independent review. On 10 December 2014, HEE announced that Professor Martin Roland, Professor of Health Services Research, University of Cambridge, will Chair the Primary Care Workforce Commission. </em></p><p> </p><p><em> </em></p><p> </p><p><em>The work was commissioned by HEE at the request of the Secretary of State for Health, due to the future health and care system requiring greater emphasis on community, primary and integrated services, and to ensure that we have the primary care workforce to meet the changing needs for healthcare, therefore it will focus on: </em></p><p> </p><p><em> </em></p><p> </p><p><em>- </em><em>patient and population need; </em></p><p> </p><p><em>- </em><em>emerging models of care to respond to the population need; </em></p><p> </p><p><em>- </em><em>maximising new skill sets; and</em></p><p> </p><p><em>- </em><em>education and training. </em></p><p> </p><p><em> </em></p><p> </p><p><em>HEE are currently implementing a number of projects to support recruitment into practice. This includes a pre-GP year pilot in five Local Education and Training Boards that provides targeted educational development for those expressing interest in general practice, and the launch of a primary and community care programme.</em></p><p> </p><p> </p><p> </p><p>HEE plan to undertake a review of the medical student intake in 2015 in the context of the HEE Strategic Framework 15, the HEE Workforce Plan for England 2015-16, and the recently published NHS England Five Year Forward View.</p><p> </p>
answering member printed Earl Howe remove filter
question first answered
less than 2015-01-26T13:00:07.307Zmore like thismore than 2015-01-26T13:00:07.307Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
2479
label Biography information for Lord Laird more like this